Rifkind RA - Search Results

1

Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM. Butler LM, et al. Among authors: rifkind ra. Cancer Res. 2000 Sep 15;60(18):5165-70. Cancer Res. 2000. PMID: 11016644

2

Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.

Kelly WK, Richon VM, O'Connor O, Curley T, MacGregor-Curtelli B, Tong W, Klang M, Schwartz L, Richardson S, Rosa E, Drobnjak M, Cordon-Cordo C, Chiao JH, Rifkind R, Marks PA, Scher H. Kelly WK, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3578-88. Clin Cancer Res. 2003. PMID: 14506144 Clinical Trial.

3

Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.

Cohen LA, Marks PA, Rifkind RA, Amin S, Desai D, Pittman B, Richon VM. Cohen LA, et al. Among authors: rifkind ra. Anticancer Res. 2002 May-Jun;22(3):1497-504. Anticancer Res. 2002. PMID: 12168829

4

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA, Richon VM. Butler LM, et al. Among authors: rifkind ra. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11700-5. doi: 10.1073/pnas.182372299. Epub 2002 Aug 20. Proc Natl Acad Sci U S A. 2002. PMID: 12189205 Free PMC article.

5

Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro.

Kutko MC, Glick RD, Butler LM, Coffey DC, Rifkind RA, Marks PA, Richon VM, LaQuaglia MP. Kutko MC, et al. Among authors: rifkind ra. Clin Cancer Res. 2003 Nov 15;9(15):5749-55. Clin Cancer Res. 2003. PMID: 14654560

6

Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation.

Marrocco DL, Tilley WD, Bianco-Miotto T, Evdokiou A, Scher HI, Rifkind RA, Marks PA, Richon VM, Butler LM. Marrocco DL, et al. Among authors: rifkind ra. Mol Cancer Ther. 2007 Jan;6(1):51-60. doi: 10.1158/1535-7163.MCT-06-0144. Epub 2007 Jan 11. Mol Cancer Ther. 2007. PMID: 17218635

7

Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro.

Coffey DC, Kutko MC, Glick RD, Swendeman SL, Butler L, Rifkind R, Marks PA, Richon VM, LaQuaglia MP. Coffey DC, et al. Med Pediatr Oncol. 2000 Dec;35(6):577-81. doi: 10.1002/1096-911x(20001201)35:6<577::aid-mpo18>3.0.co;2-3. Med Pediatr Oncol. 2000. PMID: 11107121

8

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.

Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM. Munster PN, et al. Cancer Res. 2001 Dec 1;61(23):8492-7. Cancer Res. 2001. PMID: 11731433

9

Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.

Richon VM, Rifkind RA, Marks PA. Richon VM, et al. Among authors: rifkind ra. Cell Growth Differ. 1992 Jul;3(7):413-20. Cell Growth Differ. 1992. PMID: 1419904

10

Differential modulation of protein kinase C isoforms in erythroleukemia during induced differentiation.

Leng L, Yu F, Dong L, Busquets X, Osada S, Richon VM, Marks PA, Rifkind RA. Leng L, et al. Among authors: rifkind ra. Cancer Res. 1993 Nov 15;53(22):5554-8. Cancer Res. 1993. PMID: 8221697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters